| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 24 Jul 2026 | 18 Jul 2026 |
| Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 inter alia to consider and approve Audited Consolidated Financial Results for the financial year ended 31.03.2026 along with other agenda items. | ||
| Board Meeting | 30 May 2026 | 25 May 2026 |
| Audited Results & Half Yearly Results Outcome of the Board Meeting held on 30th May, 2026 Audited Standalone Financial Results for the half year and year ended 31.03.2026 (As Per BSE Announcement Dated on 30.05.2026) | ||
| Board Meeting | 27 Feb 2026 | 24 Feb 2026 |
| Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/02/2026 inter alia to consider and approve as set below: 1) To consider and approve the proposal for variation in the objects of the Initial Public Offer (IPO). 2) To consider and grant omnibus approval for material related party transactions for the financial year 2026-27 in accordance with Section 188 of the Companies Act 2013 and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. 3) To consider and approve the adoption of the new set of Articles of Association of the Company. 4) To consider and approve the relocation of the Registered Office of the Company within the same city. 5) To consider and approve the date time and venue for convening an Extra-Ordinary General Meeting (EGM) to seek shareholders approval for the matters approved by the Board at this meeting and to authorize the issuance of the Notice of EGM and other related actions in this regard. 6) To take any other matter with the permission of the Chairman if any. Outcome of Board Meeting dated 27.02.2026 (As Per BSE Announcement Dated on: 27/02/2026) | ||
| Board Meeting | 6 Feb 2026 | 6 Feb 2026 |
| Outcome of Board Meeting dated 06.02.2026 | ||
| Board Meeting | 3 Dec 2025 | 28 Nov 2025 |
| Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/12/2025 inter alia to consider and approve 1. To consider and approve the Notice convening the Annual General Meeting (AGM) of the Company for the financial year 2024-25. 2. To review and approve the Directors Report for the financial year ended 31.03.2025. 3. To approve the appointment of the Company Secretary and Compliance Officer of the Company. 4. To acknowledge and accept the resignation of Mr. Pardeep Singh (DIN: 10345015) Director of the Company. 5. To consider and approve the acquisition of equity stake in Damaira Pharmaceuticals Private Limited. 6. To consider and approve the relocation/shifting of the Companys corporate office and authorize the Board to complete all formalities in this regard. 7. To consider and approve the proposal for voluntary transition from AS to Ind AS. 8. To consider and approve the proposal for opening and making investments in multiple foreign subsidiaries/wholly owned subsidiaries. 9. To consider and approve the Policy for Preservation of Documents of the Company 10-17. Others Outcome of Board Meeting dated 03.12.2025 (As Per BSE Announcement Dated on:03.12.2025) | ||
| Board Meeting | 10 Nov 2025 | 6 Nov 2025 |
| Astonea Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 inter alia to consider and approve 1. To consider and approve the un-audited Financial Results for the quarter/half year ended 30th September 2025. 2. To authorize Mr. Pooja Singh (DIN: 10547745) to finalise the revised distribution agreement with Astonea One Private Limited 3. To consider the appointment of Mr. Arun Kumar Tripathi as Additional Director (DIN: 08786789) 4. To consider the appointment of Mr. Pardeep Dalal as Additional Director (DIN: 02424111) 5. Any other matter with the permission of the Chair. Outcome of Board Meeting held on 10.11.2025 (As per BSE Announcement dated on: 10.11.2025) | ||
| Board Meeting | 20 Sep 2025 | 20 Sep 2025 |
| Outcome of Board Meeting dated 20.09.2025 | ||
| Board Meeting | 1 Sep 2025 | 1 Sep 2025 |
| This is to inform you that the Board of Directors of has approved the appointment of Mr. Vijay Kumar as a company secretary, KMP and Compliance officer of the company w.e.f 01st September, 2025. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
